EcoDrugPlus

Ensembl ID : ENSOMYG00000019685
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOMYG00000034193
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000021474
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSOMYG00000034178
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSOMYG00000033686
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOMYG00000033472
Gene Symbol: -
Cross references: -
508 Possible Orthologues:

Ensembl ID : ENSOMYG00000021530
Gene Symbol: PLK4
1 Cross references
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000021589
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000032832
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSOMYG00000021615
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSOMYG00000032758
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSOMYG00000021656
Gene Symbol: -
Cross references: -
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).